Hashad Yehia 4

What Happened

• Hashad Yehia, EVP of R&D and Chief Medical Officer at Bausch & Lomb Corp (BLCO), had a total of 18,865 common shares disposed via tax withholding related to vesting equity awards. The withholdings occurred on Feb 26–27, 2026 and represent shares retained to satisfy tax obligations rather than an open-market sale.
  • 2,169 shares withheld on 2026-02-26 at $18.49 per share — $40,105
  • 5,075 shares withheld on 2026-02-27 at $18.30 per share — $92,873
  • 11,621 shares withheld on 2026-02-27 at $18.30 per share — $212,664
  • Total withheld/disposed: 18,865 shares, aggregate value ≈ $345,642

Key Details

• Transaction dates and prices: Feb 26, 2026 @ $18.49; Feb 27, 2026 @ $18.30.
• Shares owned after the transactions: Not specified in the provided filing excerpt.
• Footnotes: F1 = common shares withheld to satisfy tax withholding on vested restricted share units (RSUs). F2 = common shares withheld to satisfy tax withholding on vested performance-based RSUs.
• Transaction code F indicates shares were withheld for tax withholding obligations (a routine, cashless withholding), not a discretionary sell order.
• Form 4 filed: March 2, 2026 (filing date reported in accession). No late-filing indicator was provided in the excerpt.

Context

• This was a tax-withholding/cashless withholding event tied to equity awards vesting — common corporate practice that reduces the number of shares delivered to the insider. Such withholdings are administrative and do not necessarily reflect the insider’s view on the company’s prospects.
• For retail investors: purchases or open-market sales can be more informative about insider sentiment; tax-withholding disposals are routine and typically neutral from a signaling perspective.